加拿大、美国及澳大利亚原住民风湿病患者的死亡原因与结局:一项系统综述
该系统综述汇总了加拿大、美国及澳大利亚原住民风湿病患者的死亡结局研究,共纳入12项研究。加拿大和美国原住民系统性红斑狼疮(SLE)患者较白人死亡率更高,死亡多归因于疾病进展或并发症;美国原住民类风湿关节炎(RA)和硬皮病患者死亡亦与疾病相关。
要点
- 加拿大First Nations血统SLE患者校正后生存率更低,死于狼疮及并发症频率更高。
- 美国原住民SLE患者全因死亡率高于白人,但单纯狼疮肾炎者未见此差异。
- 澳大利亚原住民SLE患者常因感染和狼疮并发症死亡;Pima印第安RA患者死亡率升高。
核心结论
- 加拿大和美国原住民SLE患者较白人死亡率增加,死亡常归因于疾病进展或并发症。
- 美国原住民RA和硬皮病患者死亡亦与疾病进展相关。
- 原住民与非原住民间风湿病严重程度和社会因素对死亡的归因比例尚未充分评估。
研究设计与样本
- 系统检索Medline、EMBASE、CINAHL及原住民和会议摘要数据库至2015年6月。
- 纳入报告加拿大、美国、澳大利亚、新西兰原住民风湿病死亡率指标的研究,最终纳入12项。
主要发现
- 5项加拿大SLE研究显示First Nations血统与校正疾病和社会因素后更低的生存率相关。
- 2项美国原住民SLE研究显示全因死亡率高于白人,但单纯狼疮肾炎者未见差异。
- 3项澳大利亚原住民SLE研究显示感染和狼疮并发症常导致死亡。
- 美国Pima印第安RA患者死亡率高于无RA者;1项美国原住民硬皮病研究显示几乎所有死亡与进展性疾病相关。
临床怎么用
- 对加拿大和美国原住民SLE患者应关注疾病进展和并发症导致的死亡风险。
- 对澳大利亚原住民SLE患者需警惕感染和狼疮并发症。
- 对原住民RA和硬皮病患者应重视疾病进展相关的死亡风险。
局限性
- 未发现新西兰原住民研究。
- 原住民与非原住民间风湿病严重程度和社会因素对死亡的归因比例尚未充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indigenous populations of Canada, America, Australia, and New Zealand have increased rates and severity of rheumatic disease. Our objective was to summarize mortality outcomes and explore disease and social factors related to mortality. METHODS: A systematic search was performed in medical (Medline, EMBASE, and CINAHL), Indigenous and conference abstract databases (to June 2015) combining search terms for Indigenous populations and rheumatic diseases. Studies were included if they reported measures of mortality (crude frequency, mortality rate, survival, and potential years of life lost (PYLL)) in Indigenous populations from the four countries. RESULTS: Of 5269 titles and abstracts identified, 504 underwent full-text review and 12 were included. No studies from New Zealand were found. In five Canadian studies of systemic lupus erythematosus (SLE) patients, First Nations ethnicity was associated with lower survival after adjusting for disease and social factors, and an increased frequency of death from lupus and its complications compared to Caucasians was found. All-cause mortality was higher in Native Americans (n = 2 studies) relative to Whites with SLE after adjusting for disease and social factors, but not in those with lupus nephritis alone. Australian Aborigines with SLE frequently developed infection and lupus complications leading to death (n = 3 studies). Mortality rates were increased in Pima Indians in the United States with rheumatoid arthritis (RA) compared to those without RA. One study in Native Americans with scleroderma found nearly all deaths were related to progressive disease. CONCLUSIONS: Canadian and American Indigenous populations with SLE have increased mortality rates compared to Caucasian populations. Mortality in Canadian and Australian Indigenous populations with SLE, and in Native American populations with RA and scleroderma, is frequently attributed to disease progression or complications. The proportional attribution of rheumatic disease severity and social factors to mortality and complications leading to death between Indigenous and non-Indigenous populations has not been fully evaluated.
引用
- Hurd K, Barnabe C. Mortality causes and outcomes in Indigenous populations of Canada, the United States, and Australia with rheumatic disease: A systematic review. Semin Arthritis Rheum. 2017. PMID: 28823732. doi:10.1016/j.semarthrit.2017.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。